Home
Idorsia

Idorsia Market Share Analysis for August 2026

Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland.

Health > Biotechnology and Pharmaceuticals

Domainidorsia.com

Year Founded2017

Employees501 - 1000

Annual Revenue$200M - $500M

Idorsia

Idorsia (including company regionals)

idorsia.com

See more website traffic and engagement information

Idorsia Revenue up to August 2026 is 200M - 500M

revenue generated by Idorsia top domains

Idorsia top domains revenue over 3 years

Revenue for Idorsia top domains

idorsia.com200M - 500M

See more with Sales Intelligence

Idorsia Stock price in August 2026

Idorsia stock is traded under the ticker #IDIA. Below you can review Idorsia stock performance in the past 12 months up to August 2026

Total visits to Idorsia's top domains

Understand Idorsia market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

idorsia.com32.3K

See more with Sales Intelligence

Avg. visit duration in Idorsia's top domains

Analyze Idorsia engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

idorsia.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Idorsia's top domains

See how Idorsia keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

idorsia.com1.82

See more with Sales Intelligence

Idorsia top competitors by domain

Top similar sites in August 2026, ranked by their affinity

janssen.comCompany NameJanssenEmployees> 10001HQUnited States, New Jersey, TitusvilleAnnual revenue> $1BTotal visits6.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Idorsia

These are the website technologies, by industry, used by Idorsia top domains

Advertising (4)

DoubleClick

Email Services (3)

G Suite

Marketing (3)

Google Marketing Platform

Audio Video Media (2)

Vimeo

More Technologies

10

See all

News & Signals from Idorsia

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIdorsia Ltd had revenue of $113M on Apr 1st '26.* QUVIVIQ (daridorexant) sales reached CHF 91 million in the first half of 2026, marking a 62% year-over-year increase.

NewsIdorsia Ltd partnered with Jamjoom Pharma on Jul 27th '26.Idorsia Ltd (SIX: IDIA) has entered into an exclusive agreement with Jamjoom Pharmaceuticals Factory Co. ("Jamjoom Pharma") for the distribution and commercialization of QUVIVIQ(TM)(daridorexant), Idorsia's treatment for adults with insomnia, in Saudi Arabia and the Levant region.

NewsIdorsia Ltd will hire Begoña Carreño-Gómez as Chief Business Development Officer and member of the Executive Committee on Nov 1st '26.Idorsia has also appointed Begoña Carreño-Gómez as Chief Business Development Officer and member of the Executive Committee, effective November 1, 2026.